Chemical inhibitors of 1110020A21Rik can effectively impede its function through various biochemical pathways. Staurosporine, a potent protein kinase inhibitor, can hinder the kinase activity essential for the function of 1110020A21Rik. By preventing the phosphorylation process, which is crucial for the activation and function of many proteins, Staurosporine ensures that proteins like 1110020A21Rik are not activated improperly. Bisindolylmaleimide I operates by specifically targeting protein kinase C, which is integral to the phosphorylation cascade. This inhibitor can indirectly lead to the decreased phosphorylation and subsequent inactivity of 1110020A21Rik, assuming protein kinase C is upstream in its activation process. Similarly, LY294002 and Wortmannin are inhibitors of PI3K, which is upstream of AKT phosphorylation. Inhibition of this pathway can inhibit 1110020A21Rik if its activity is contingent upon AKT signaling. Rapamycin, by inhibiting mTOR, can suppress the mTOR signaling cascade, potentially leading to the inhibition of 1110020A21Rik, presuming that 1110020A21Rik requires mTOR activity.
In the MAPK pathway, U0126 and PD98059 serve as inhibitors of MEK1/2, which is vital for ERK pathway activity. By inhibiting MEK, these chemicals can inhibit ERK pathway signaling, which could be essential for the function of 1110020A21Rik. SB203580 and SP600125 inhibit the p38 MAPK and JNK pathways, respectively. By targeting these kinases, they can lead to an inhibition of 1110020A21Rik if its activity is dependent on the p38 MAPK or JNK signaling. Additionally, Dasatinib, a tyrosine kinase inhibitor, can prevent the activation of 1110020A21Rik by inhibiting upstream tyrosine kinases responsible for its activation. Lapatinib, which targets EGFR and HER2, can also inhibit 1110020A21Rik if its functional activity relies on the signaling pathways initiated by these receptor tyrosine kinases. Lastly, PP2, which targets Src family kinases, can inhibit 1110020A21Rik by reducing the activity of Src family kinases that might regulate the function of 1110020A21Rik. Collectively, these chemicals target different kinases and pathways that are crucial for the activation and function of 1110020A21Rik, thereby achieving functional inhibition through various well-established mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
As a potent inhibitor of protein kinases, Staurosporine can inhibit 1110020A21Rik by blocking the kinase activity required for its function. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
This inhibitor targets protein kinase C, which, upon inhibition, can reduce the phosphorylation of downstream proteins including 1110020A21Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
This chemical inhibits PI3K, potentially leading to a decrease in AKT phosphorylation and subsequent inhibition of 1110020A21Rik if it is AKT dependent. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
As an inhibitor of PI3K, Wortmannin can decrease AKT activity which might be necessary for 1110020A21Rik activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
By forming a complex with FKBP12, Rapamycin inhibits mTOR, which could be crucial for 1110020A21Rik function if it is mTOR dependent. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
This MEK1/2 inhibitor can reduce ERK pathway activity, leading to the inhibition of 1110020A21Rik if it relies on the ERK pathway for its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibiting MEK specifically can lead to the inhibition of the ERK pathway and potentially the activity of 1110020A21Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Targeting p38 MAP kinase with this inhibitor could lead to inhibition of 1110020A21Rik if p38 MAPK is involved in its regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK that could lead to the inhibition of 1110020A21Rik if JNK signaling is necessary for its activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
As a tyrosine kinase inhibitor, Dasatinib could inhibit the activity of 1110020A21Rik by inhibiting kinases that regulate its function. | ||||||